CombinatoRx
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
650 Albany St, Boston, Massachusetts, 02...Phone Number
(617) 425-7000Website
www.combinatorx.comRevenue
$23.1 MillionIndustry
About CombinatoRx
CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical development. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease. The lead programs in the CombinatoRx portfolio are advancing into later stage clinical trials based on the strength of multiple positive Phase 2a results. This portfolio is internally generated from the CombinatoRx proprietary drug discovery technology which provides a renewable and previously untapped source of novel drug candidates. The Company was founded in 2000 and is located in Cambridge, Massachusetts.Explore more
CombinatoRx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to CombinatoRx
Compare insights from companies similar to CombinatoRx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$33.6M
201-500
Public
$1.2B
2003
RM
Rishma MerchantSenior Director and Chief of Staff, Clinical Operations
CombinatoRx Tech Stack
A closer look at the technologies used by CombinatoRx
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CombinatoRx
Sign Up For FreeTo access detailed company insights
CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical development. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease. The lead pr... Read More
